Abstract

Somatic symptom disorder (SSD) is a form of mental illness that causes one or more distressing somatic symptoms leading to a significant disruption to everyday life, characterized by excessive thoughts, feelings, or behaviors related to these symptoms. While SSD is characterized by significant discomfort in some parts of the body, these symptoms are not related to any known medical condition and therefore it cannot be diagnosed using any medical instrument examination. Currently available treatments for SSD, including drug therapy and psychotherapy (such as cognitive behavioral therapy), usually improve psychiatric symptoms, but the results are often disappointing. Furthermore, SSD is often comorbid with anxiety and depression (75.1 and 65.7%, respectively). Importantly, interventions targeting the anterior limb of the internal capsule (ALIC; e.g., deep brain stimulation and thermal ablation) can effectively treat various mental disorders, such as refractory obsessive-compulsive disorder, depression, and eating disorders, suggesting that it may also be effective for treating the depressive symptoms associated with SSD comorbidity. In this report, a 65-year-old woman diagnosed with SSD accompanied with depression and anxiety underwent bilateral anterior capsulotomy. The patient complained of nausea and vomiting, swelling of the hilum of the liver for 14 years, weakness of the limbs for 13 years, and burning pain in the esophagus for 1 year. Psychiatric and neuropsychological assessments were conducted to record the severity of the patients' symptoms and the progression of postoperative symptoms. The patient's somatization, depression, and anxiety symptoms as well as quality of life improved significantly and steadily; thus, anti-depressive and anti-anxiety medication were stopped. However, the patient developed new somatization symptoms, including dizziness, headache, and sternal pain, 10 months after the operation. Therefore, the patient resumed taking flupentixol and melitracen in order to control the new symptoms. This study shows that bilateral anterior capsulotomy appears to be a complementary treatment for refractory SSD with depressive and anxiety symptoms. Furthermore, postoperative use of anxiolytic and antidepressant medications may be useful for controlling future somatization symptoms.

Highlights

  • Somatic symptom disorder (SSD) is a mental disorder that manifests as one or more distressing somatic symptoms that result in a significant disruption to daily life due to excessive thoughts, feelings, or behaviors related to these symptoms (American Psychiatric Association, 2013)

  • Interventions targeting the anterior limb of the internal capsule (ALIC), including ablative procedures and deep brain stimulation (DBS), are known to be effective for treating refractory severe depression and anxiety

  • The evaluation team evaluated the patients’ clinical symptoms, social function, and mental state using the Mini-Mental State Examination (MMSE), HAMA, HAMD, Symptom Checklist-90 (SCL-90), World Health Organization Quality of Life-Brief (WHOQOL-BREF), Patient Health Questionnaire-15 (PHQ-15), FIGURE 1 | A computed tomography slice of representative ALIC lesions created by bilateral anterior capsulotomy, taken on postoperative day 1

Read more

Summary

INTRODUCTION

Somatic symptom disorder (SSD) is a mental disorder that manifests as one or more distressing somatic symptoms that result in a significant disruption to daily life due to excessive thoughts, feelings, or behaviors related to these symptoms (American Psychiatric Association, 2013). In 2011, she was admitted to the psychiatric department with a diagnosis of “SSD with depressive and anxiety symptoms.” She received various medications and felt that her symptoms (abdominal pain, abdominal distension, anal distension, weakness, and distension of the limbs) improved to a greater degree when she took flupentixol and melitracen (one tablet, b.i.d.). The results were as follows: Patient Health Questionnaire-15 (PHQ-15): 20 points, Hamilton Rating Scale for Depression-17 (HAMD-17): 32 points, Hamilton Anxiety Rating Scale-14 (HAMA-14): 28 points, Symptom Checklist-90 (SCL-90): 156 points, Mini-Mental State Examination (MMSE): 27 points, and Pittsburgh Sleep Quality Index (PSQI): 27 points. The evaluation team evaluated the patients’ clinical symptoms, social function, and mental state using the MMSE, HAMA, HAMD, SCL-90, World Health Organization Quality of Life-Brief (WHOQOL-BREF), PHQ-15, FIGURE 1 | A computed tomography slice of representative ALIC lesions created by bilateral anterior capsulotomy, taken on postoperative day 1.

DISCUSSION
Findings
ETHICS STATEMENT
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call